EXAMINING THE LATEST ADVANCES IN CAR AND TCR THERAPIES
Part of the Research & Technology Series, this conference explores the exciting field of cell and gene therapy in immuno-oncology.
The modification of patient and donor t cells offers a potent weapon in the fight against cancer, and with the recent regulatory approval, several CAR-T Cell products in the US and Europe these therapies stand poised to enter the clinic.
This conference offers experts working in the pharmaceutical industry and academia the opportunity to explore the latest developments in CAR T cell therapies, and the up-and-coming field of T Cell Receptor therapies. Presentations will explore design and development strategies for the modification of patient and donor t cells, receptor engineering and target selection, and will review the advantages and challenges remaining in their use.